Chemours Co
NYSE:CC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.5727
30.7849
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Chemours Co
Chemours Co
Cash & Cash Equivalents
Chemours Co
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Chemours Co
NYSE:CC
|
Cash & Cash Equivalents
$596m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Huntsman Corp
NYSE:HUN
|
Cash & Cash Equivalents
$330m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
LSB Industries Inc
NYSE:LXU
|
Cash & Cash Equivalents
$42.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
|
Chemours Co
Glance View
In the ever-evolving landscape of chemical manufacturing, Chemours Co. stands out as a testament to adaptation and innovation. Spun off from DuPont in 2015, Chemours made its mark by inheriting a robust portfolio that included titanium technologies, fluoroproducts, and chemical solutions. With titanium dioxide as a cornerstone of its operations, the company supplies essential pigments that imbue products like coatings and plastics with their vibrant colors and brightness. However, it’s the fluoroproducts segment that tells the more dynamic side of Chemours' story. The division is responsible for producing Teflon and other fluoropolymers, which find their way into countless applications from automotive to electronics. These products not only define durability and non-stick conveniences in daily life but also drive a significant portion of the company's revenue. Despite the legacy grounding Chemours in proven cash flows, it's the company’s pivot towards sustainability and eco-innovation that paints a compelling portrait of its future. Launching its Opteon line of refrigerants, designed to minimize environmental impact, underscores Chemours’ commitment to leading with green solutions amid a backdrop of global climate concerns. Further pushing the envelope with its “Chemours Future of Chemistry” initiative, the company aims to leverage its scientific prowess to develop products that are not only profitable but sustainable. Operating in this dual role of a traditional powerhouse and a forward-looking innovator, Chemours navigates the complexities of modern chemical demands by aligning profitability with a responsible outlook.
See Also
What is Chemours Co's Cash & Cash Equivalents?
Cash & Cash Equivalents
596m
USD
Based on the financial report for Sep 30, 2024, Chemours Co's Cash & Cash Equivalents amounts to 596m USD.
What is Chemours Co's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-3%
Over the last year, the Cash & Cash Equivalents growth was -30%. The average annual Cash & Cash Equivalents growth rates for Chemours Co have been -17% over the past three years , -3% over the past five years .
You don't have any saved screeners yet